Author:
VanCott Anne C,Cramer Joyce A,Copeland Laurel A,Zeber John E,Steinman Michael A,Dersh Jeffrey J,Glickman Mark E,Mortensen Eric M,Amuan Megan E,Pugh Mary Jo
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. U.S. Food and Drug Administration: Center for Drug Evaluation and Research: Information for healthcare professionals: suicidality and antiepileptic drugs [online]. Accessed July 18, 2000., [ http://www.fda.gov/cder/drug/InfoSheets/HCP/antiepilepticsHCP.htm ]
2. Avorn J: Drug warnings that can cause fits--communicating risks in a data-poor environment. N Engl J Med. 2008, 359: 991-994. 10.1056/NEJMp0805922.
3. Nilsson L, Ahlbom A, Farahmand BY, Asberg M, Tomson T: Risk factors for suicide in epilepsy: a case control study. Epilepsia. 2002, 43: 644-651. 10.1046/j.1528-1157.2002.40001.x.
4. Zetin M, Hoepner CT: Relevance of exclusion criteria in antidepressant clinical trials: a replication study. J Clin Psychopharmacol. 2007, 27: 295-301. 10.1097/JCP.0b013e318058263f.
5. Silverman MM, Berman AL, Sanddal ND, O'Carroll PW, Joiner TE: Rebuilding the Tower of Bable: A Revised Nomenclature for the Study of Suicide and Suicidal Behaviors Part 1: Background, Rationale, and Methodology. Suicide and Life-Threatening Behavior. 2007, 37: 248-263. 10.1521/suli.2007.37.3.248.
Cited by
71 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献